By PTI Oct 20, 2020 4:12:39 PM IST (Published)
Follow real-time updates on Union Budget 2023Catch exclusive videos on Union Budget 2023 from CNBC-TV18
Dr Reddy's Laboratories on Tuesday said it has launched overthecounter (OTC) drug Famotidine tablets, used to treat gastroesophageal reflux disease, in the American market. The company has launched the product, which is equivalent to Johnson & Johnson's Pepcid AC, in the US after getting approval from the US Food and Drug Administration (USFDA), Dr Reddy's Laboratories said in a statement. Famotidine tablets are used to prevent and relieve heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages. This launch will help us fulfil an important therapy gap created in antacids market due to Ranitidine withdrawal," Dr Reddy's Laboratories North America Generics CEO Marc Kikuchi said.
Dr Reddy’s Laboratories on Tuesday said it has launched over-the-counter (OTC) drug Famotidine tablets, used to treat gastroesophageal reflux disease, in the American market. The company has launched the product, which is equivalent to Johnson & Johnson’s Pepcid AC, in the US after getting approval from the US Food and Drug Administration (USFDA), Dr Reddy’s Laboratories said in a statement.
Recommended Articles
View All
World Cancer Day 2023: Early detection is crucial for reducing the global burden
Feb 4, 2023 IST5 Min(s) Read
World Cancer Day 2023: A way forward to better management of cancer this year!
Feb 4, 2023 IST6 Min(s) Read
Pakistan economy at alarming level as foreign reserves drop to $3.1 billion from $16.6 billion in a year
Feb 3, 2023 IST3 Min(s) Read
FM Nirmala Sitharaman speaks on inflation, taxes, GDP and more. Read the full interview here
Feb 3, 2023 IST37 Min(s) Read
Famotidine tablets are used to prevent and relieve heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages.
This launch will help us fulfil an important therapy gap created in antacids market due to Ranitidine withdrawal,” Dr Reddy’s Laboratories North America Generics CEO Marc Kikuchi said.
The Pepcid AC brand and generic versions had US sales of around USD 211 million for the 12 months ended in August 2020.
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!